Pilot Study: Alteration of Deleted in Liver Cancer1 and Phosphorylated Focal Adhesion Kinase Y397 Cytoplasmic Expression and the Prognostic Value in Advanced Epithelial Ovarian Carcinoma

被引:8
作者
Fan, Dong-Mei [1 ,2 ]
Shi, Hui-Rong [1 ]
机构
[1] Zhengzhou Univ, Dept Obstet & Gynecol, Affiliated Hosp 1, Zhengzhou 450052, Peoples R China
[2] Henan Univ Sci & Technol, Affiliated Hosp 1, Dept Gynecol, Luoyang 471003, Peoples R China
关键词
DLC1; gynecologic cancers; ovarian carcinoma; prognosis; p-FAK; TUMOR-SUPPRESSOR GENE; GTPASE-ACTIVATING PROTEIN; HEPATOCELLULAR-CARCINOMA; CELL-PROLIFERATION; DLC-1; INVASION; RHO; MIGRATION; SURVIVAL; GROWTH;
D O I
10.3390/ijms12128489
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Background: Deletion in liver cancer gene (DLC1) and phosphorylated focal adhesion kinase (p-FAK) have recently been reported as metastasis-related genes. However, the roles and prognostic values of their expression in epithelial ovarian carcinomas (EOCs) remain unclear. Methods: The expression and prognostic value of DLC1 and p-FAK Y397 in EOC were evaluated by immunohistochemistry and multivariate analysis. Results: Low expression of DLC1 and high expression of p-FAK Y397 were found in the 76 cases of EOC. The expression of DLC1 and p-FAK Y397 were negatively correlated. Multivariate analysis showed that the combination of them was an independent prognostic marker of EOC (P = 0.0319). Conclusions: DLC1 and pFAK Y397 had an association with the clinicopathologic characteristics of EOC. Expression of neither of these genes was a prognostic factor alone, but the combination revealed a significant prognostic value in the 60 cases of advanced stage EOC.
引用
收藏
页码:8489 / 8501
页数:13
相关论文
共 40 条
[1]   Evaluation of CD44 and CD44v6 in colorectal carcinoma patients: Soluble forms in relation to tumor tissue expression and metastasis [J].
Amirghofran Z. ;
Jalali S.A. ;
Hosseini S.V. ;
Vasei M. ;
Sabayan B. ;
Ghaderi A. .
Journal of Gastrointestinal Cancer, 2008, 39 (1-4) :73-78
[2]   Ovarian Cancer [J].
Cho, Kathleen R. ;
Shih, Ie-Ming .
ANNUAL REVIEW OF PATHOLOGY-MECHANISMS OF DISEASE, 2009, 4 :287-313
[3]   Focal adhesion kinase (FAK), a multifunctional protein [J].
Cornillon, J ;
Campos, L ;
Guyotat, D .
M S-MEDECINE SCIENCES, 2003, 19 (6-7) :743-752
[4]   A prognostic gene expression index in ovarian cancer - validation across different independent data sets [J].
Denkert, Carsten ;
Budczies, Jan ;
Darb-Esfahani, Silvia ;
Gyoerffy, Balazs ;
Sehouli, Jalid ;
Koensgen, Dominique ;
Zeillinger, Robert ;
Welchert, Wilko ;
Noske, Aurelia ;
Buckendahl, Ann-Christin ;
Mueller, Berit M. ;
Dietel, Manfred ;
Lage, Hermann .
JOURNAL OF PATHOLOGY, 2009, 218 (02) :273-280
[5]   DLC-1: a Rho GTPase-activating protein and tumour suppressor [J].
Durkin, Marian E. ;
Yuan, Bao-Zhu ;
Zhou, Xiaoling ;
Zimonjic, Drazen B. ;
Lowy, Douglas R. ;
Thorgeirsson, Snorri S. ;
Popescu, Nicholas C. .
JOURNAL OF CELLULAR AND MOLECULAR MEDICINE, 2007, 11 (05) :1185-1207
[6]   RNA interference targeting focal adhesion kinase enhances pancreatic adenocarcinoma gemcitabine chemosensitivity [J].
Duxbury, MS ;
Ito, H ;
Benoit, E ;
Zinner, MJ ;
Ashley, SW ;
Whang, EE .
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 2003, 311 (03) :786-792
[7]   Clinical significance of circulating tumor cells detected by an invasion assay in peripheral blood of patients with ovarian cancer [J].
Fan, Tina ;
Zhao, Qiang ;
Chen, John J. ;
Chen, Wen-Tien ;
Pearl, Michael L. .
GYNECOLOGIC ONCOLOGY, 2009, 112 (01) :185-191
[8]   The RhoGAP protein DLC-1 functions as a metastasis suppressor in breast cancer cells [J].
Goodison, S ;
Yuan, G ;
Sloan, D ;
Kim, R ;
Li, C ;
Popescu, NC ;
Urquidi, V .
CANCER RESEARCH, 2005, 65 (14) :6042-6053
[9]   Rho GTPases and the actin cytoskeleton [J].
Hall, A .
SCIENCE, 1998, 279 (5350) :509-514
[10]   Loss of RUNX3 Expression Correlates with Differentiation, Nodal Metastasis, and Poor Prognosis of Gastric Cancer [J].
Hsu, Ping-I. ;
Hsieh, Hsiao-Ling ;
Lee, Jihjong ;
Lin, Li-Fang ;
Chen, Hui-Chun ;
Lu, Pei-Jung ;
Hsiao, Michael .
ANNALS OF SURGICAL ONCOLOGY, 2009, 16 (06) :1686-1694